D-133-2013 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-133-2013 was initiated by West-Ward Pharmaceutical Corp. on Dec 5, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions. The recall status is terminated (terminated May 16, 2014). Affected quantity: 60,289 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 30, 2013
Initiation Date
Dec 5, 2012
Termination Date
May 16, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60,289 bottles

Product description

PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Reason for recall

Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-133-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-133-2013. Report a data issue: hello@regdatalab.com.